Masimo Corporation $MASI Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas cut its stake in Masimo Corporation (NASDAQ:MASI) by 12.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,671 shares of the medical equipment provider’s stock after selling 1,592 shares during the period. Teacher Retirement System of Texas’ holdings in Masimo were worth $1,963,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Twin Tree Management LP acquired a new position in shares of Masimo during the 1st quarter worth approximately $29,000. Hilltop National Bank purchased a new stake in Masimo during the 2nd quarter worth $37,000. Anderson Financial Strategies LLC purchased a new stake in Masimo during the 1st quarter worth $49,000. Quarry LP lifted its holdings in Masimo by 253.5% in the 1st quarter. Quarry LP now owns 449 shares of the medical equipment provider’s stock worth $75,000 after buying an additional 322 shares in the last quarter. Finally, Ballentine Partners LLC acquired a new position in Masimo in the 1st quarter worth $206,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Stock Performance

Shares of MASI opened at $144.96 on Tuesday. The company’s fifty day moving average is $144.80 and its 200-day moving average is $154.07. Masimo Corporation has a 12 month low of $133.70 and a 12 month high of $194.88. The firm has a market cap of $7.87 billion, a price-to-earnings ratio of -17.01 and a beta of 1.28. The company has a quick ratio of 1.61, a current ratio of 2.14 and a debt-to-equity ratio of 0.57.

Masimo (NASDAQ:MASI) last posted its earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The business had revenue of $617.00 million for the quarter. Equities analysts expect that Masimo Corporation will post 4.1 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director William R. Jellison purchased 3,000 shares of Masimo stock in a transaction on Monday, August 11th. The stock was purchased at an average cost of $145.98 per share, with a total value of $437,940.00. Following the acquisition, the director directly owned 4,790 shares in the company, valued at approximately $699,244.20. This trade represents a 167.60% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 9.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on MASI. Piper Sandler upped their target price on shares of Masimo from $200.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 6th. BTIG Research reiterated a “buy” rating and issued a $198.00 price objective on shares of Masimo in a report on Thursday, September 11th. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a research note on Wednesday, October 8th. Zacks Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Finally, Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday, October 14th. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $194.60.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.